Roche drug scores label expansion for earlier use in lung cancer

The latest stories trending on MedCity News.

Editor's Pick

Top Story Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer The FDA expanded the approval of Roche's Alecensa to include adjuvant treatment of non-small cell lung cancer. The targeted therapy addresses cancers driven by the ALK genetic mutation. Time is Running Out! Act fast! Advance Rate Tickets for MedCity INVEST 2024 end on April 26. Connect with industry leaders, explore cutting-edge investment trends, and create lasting relationships at this exclusive event. Secure your spot today and get ready to unlock new opportunities in healthcare innovation! Get Your Tickets NOW

Featured News

Benefit Consultants: How Are You Guiding Employers on Cost Management? Cost management is one of the most important healthcare benefit issues for clients right now. How are you guiding and advising your clients in the costly areas of drug/specialty pharmacy, cancer care, and more? Take part in our survey and share your insights! Emerging Mental Health Care Options for EDs in Crisis Optimizing care journeys based on patient needs and using collaborative resources outside of the ED can result in effective and efficient behavioral care, regardless of volume.  Ilant Health Raises Extended Seed Round of $5.5M for Obesity Management Platform Ilant Health extended its seed round from $3 million to $5.5 million. The company garnered interest from LifeX Ventures, Celtic House Asia Partners and Cornucopian Capital.

Resources

MedCity Debunked: Change Healthcare Cybersecurity Attack, 23andMe Relevance and Startup Tips In this month's episode, we talk about the massive cyberattack at Change Healthcare that brought the healthcare payment processing clearinghouse to its knees. How were providers, patients, pharmacies, and health systems affected? We also talk about 23AndMe and its relevance in the marketplace. Finally, as a journalist and investor, we offer advice to startups on what is a turn-off for us.  Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe